Drug · DIN 02232568
REQUIP
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since March 2, 2018; first marketed September 9, 1997.
- Drug Identification Number (DIN)
- 02232568
- Company (DIN owner)
- Glaxosmithkline IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ropinirole N04BC04
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ROPINIROLE (ROPINIROLE HYDROCHLORIDE) | 2 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 22, 2001: NOC 2550New Drug Submission (NDS) · Change in manufacturer name
- August 19, 1997: NOC 4051New Drug Submission (NDS)
Other DINs named REQUIP
- DIN 02232565 · Cancelled Post Market
- DIN 02232567 · Cancelled Post Market
- DIN 02232569 · Cancelled Post Market